Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
Chris A ReesDavid C BrousseauDaniel M CohenAnthony VillellaCarlton DampierKathleen BrownAndrew CampbellCorrie E ChumpitaziGladstone AireweleTodd ChangChristopher DentonAngela EllisonAlexis ThompsonFahd AhmadNitya BakshiKeli D ColemanSara LeibovichDeborah LeakeDunia HatabahHagar WilkinsonMichelle RobinsonT Charles CasperElliott VichinskyClaudia R Morrisnull nullPublished in: Trials (2023)
The STArT Trial was registered in ClinicalTrials.gov on April 9, 2021, and enrollment began on June 21, 2021 (NCT04839354).